Literature DB >> 31411525

Dysfunction of iPSC-derived endothelial cells in human Hutchinson-Gilford progeria syndrome.

Gianfranco Matrone1,2, Rajarajan A Thandavarayan1, Brandon K Walther1, Shu Meng1, Anahita Mojiri1, John P Cooke1.   

Abstract

Children with Hutchinson-Gilford progeria syndrome (HGPS) succumb to myocardial infarction and stroke in their teen years. Endothelial dysfunction is an early event in more common forms of atherosclerosis. Endothelial pathobiology may contribute to HGPS, but a comprehensive characterization of endothelial function in HGPS has not been performed. iPSCs derived from fibroblasts of HGPS patients or unaffected relatives were differentiated into endothelial cells (ECs). Immunofluorescent signal of the pluripotent stem cell markers SSEA4, Oct4, Sox2 and TRAI-60 was similar in HGPS or control iPSCs. Following the differentiation, FACS analysis and immunocytochemistry for CD31 and CD144 revealed a smaller percentage of ECs from HGPS iPSCs. Immunostaining for Lamin A revealed nuclear dysmorphology in HGPS iPSC-ECs. Furthermore, these cells were significantly larger and rounded, and they proliferated less, features which are typical of senescent endothelial cells. HGPS iPSC-ECs manifested less Dil-Ac-LDL uptake; less DAF-2DA staining for nitric oxide generation and formed fewer networks in matrigel in vitro. In immunodeficient mice injected with iPSC-ECs, HGPS iPSC-ECs generated a sparser vascular network compared to the control, with reduced capillary number. Telomere length (T/S ratio) of HGPS iPSC-EC was reduced as assessed by mmqPCR. iPSC-ECs derived from HGPS patients have dysmorphic appearance, abnormal nuclear morphology, shortened telomeres, reduced replicative capacity and impaired functions in vitro and in vivo. Targeting the endothelial abnormality in patients with HGPS may provide a new therapeutic avenue for the treatment of this condition. Abbreviations: HGPS: Hutchinson-Gilford progeria syndrome; ZMPSTE24: Zinc metallopeptidase STE24; FTI: Farnesyltransferase inhibitors; VSMCs: Vascular smooth muscle cells; iPSC: Induced pluripotent stem cells; EC: Endothelial cells; hTERT: Human telomerase reverse transcriptase; VEGF: vascular endothelial growth factor; DAF-FM DA: 3-Amino, 4-aminomethyl-2',7'-difluorofluorescein diacetate; BMP4: Bone Morphogenetic Protein 4; mmqPCR: mono chrome multiplex PCR; SCG: single-copy gene; CSI: Cell shape index.

Entities:  

Keywords:  Progeria; dysfunction; endothelial cells; endothelium; iPSC; telomeres

Mesh:

Substances:

Year:  2019        PMID: 31411525      PMCID: PMC6738911          DOI: 10.1080/15384101.2019.1651587

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  59 in total

Review 1.  Review: nuclear lamins--structural proteins with fundamental functions.

Authors:  Y Gruenbaum; K L Wilson; A Harel; M Goldberg; M Cohen
Journal:  J Struct Biol       Date:  2000-04       Impact factor: 2.867

Review 2.  Natural history and histological classification of atherosclerotic lesions: an update.

Authors:  H C Stary
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

Review 3.  Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions.

Authors:  R Virmani; F D Kolodgie; A P Burke; A Farb; S M Schwartz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-05       Impact factor: 8.311

4.  Lamin a truncation in Hutchinson-Gilford progeria.

Authors:  Annachiara De Sandre-Giovannoli; Rafaëlle Bernard; Pierre Cau; Claire Navarro; Jeanne Amiel; Irène Boccaccio; Stanislas Lyonnet; Colin L Stewart; Arnold Munnich; Martine Le Merrer; Nicolas Lévy
Journal:  Science       Date:  2003-04-17       Impact factor: 47.728

5.  A progeroid syndrome in mice is caused by defects in A-type lamins.

Authors:  Leslie C Mounkes; Serguei Kozlov; Lidia Hernandez; Teresa Sullivan; Colin L Stewart
Journal:  Nature       Date:  2003-05-15       Impact factor: 49.962

Review 6.  DNA double-strand breaks: signaling, repair and the cancer connection.

Authors:  K K Khanna; S P Jackson
Journal:  Nat Genet       Date:  2001-03       Impact factor: 38.330

7.  Histological and ultrastructural features of atherosclerosis in progeria.

Authors:  W E Stehbens; S J Wakefield; E Gilbert-Barness; R E Olson; J Ackerman
Journal:  Cardiovasc Pathol       Date:  1999 Jan-Feb       Impact factor: 2.185

8.  eNOS activity is reduced in senescent human endothelial cells: Preservation by hTERT immortalization.

Authors:  H Matsushita; E Chang; A J Glassford; J P Cooke; C P Chiu; P S Tsao
Journal:  Circ Res       Date:  2001-10-26       Impact factor: 17.367

9.  Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome.

Authors:  Maria Eriksson; W Ted Brown; Leslie B Gordon; Michael W Glynn; Joel Singer; Laura Scott; Michael R Erdos; Christiane M Robbins; Tracy Y Moses; Peter Berglund; Amalia Dutra; Evgenia Pak; Sandra Durkin; Antonei B Csoka; Michael Boehnke; Thomas W Glover; Francis S Collins
Journal:  Nature       Date:  2003-04-25       Impact factor: 49.962

10.  Accumulation of mutant lamin A causes progressive changes in nuclear architecture in Hutchinson-Gilford progeria syndrome.

Authors:  Robert D Goldman; Dale K Shumaker; Michael R Erdos; Maria Eriksson; Anne E Goldman; Leslie B Gordon; Yosef Gruenbaum; Satya Khuon; Melissa Mendez; Renée Varga; Francis S Collins
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-07       Impact factor: 11.205

View more
  8 in total

1.  Telomerase therapy reverses vascular senescence and extends lifespan in progeria mice.

Authors:  Anahita Mojiri; Brandon K Walther; Chongming Jiang; Gianfranco Matrone; Rhonda Holgate; Qiu Xu; Elisa Morales; Guangyu Wang; Jianhua Gu; Rongfu Wang; John P Cooke
Journal:  Eur Heart J       Date:  2021-11-07       Impact factor: 35.855

2.  Progerin-Induced Impairment in Wound Healing and Proliferation in Vascular Endothelial Cells.

Authors:  Yizhi Jiang; Julie Y Ji
Journal:  Front Aging       Date:  2022-03-14

Review 3.  Pharmacotherapy to gene editing: potential therapeutic approaches for Hutchinson-Gilford progeria syndrome.

Authors:  Saurabh Saxena; Sanjeev Kumar
Journal:  Geroscience       Date:  2020-02-11       Impact factor: 7.713

4.  Endothelial and systemic upregulation of miR-34a-5p fine-tunes senescence in progeria.

Authors:  Christina Manakanatas; Santhosh Kumar Ghadge; Azra Agic; Fatih Sarigol; Petra Fichtinger; Irmgard Fischer; Roland Foisner; Selma Osmanagic-Myers
Journal:  Aging (Albany NY)       Date:  2022-01-12       Impact factor: 5.682

5.  Vascular senescence in progeria: role of endothelial dysfunction.

Authors:  Qiu Xu; Anahita Mojiri; Luay Boulahouache; Elisa Morales; Brandon K Walther; John P Cooke
Journal:  Eur Heart J Open       Date:  2022-07-28

6.  MicroRNA-151 Attenuates Apoptosis of Endothelial Cells Induced by Oxidized Low-density Lipoprotein by Targeting Interleukin-17A (IL-17A).

Authors:  Fanfeng Chen; Xiaoning Ye; Haote Jiang; Guanxia Zhu; Shouliang Miao
Journal:  J Cardiovasc Transl Res       Date:  2020-09-25       Impact factor: 4.132

Review 7.  Molecular and Cellular Mechanisms Driving Cardiovascular Disease in Hutchinson-Gilford Progeria Syndrome: Lessons Learned from Animal Models.

Authors:  Ignacio Benedicto; Beatriz Dorado; Vicente Andrés
Journal:  Cells       Date:  2021-05-11       Impact factor: 6.600

8.  Fli1+ cells transcriptional analysis reveals an Lmo2-Prdm16 axis in angiogenesis.

Authors:  Gianfranco Matrone; Bo Xia; Kaifu Chen; Martin A Denvir; Andrew H Baker; John P Cooke
Journal:  Proc Natl Acad Sci U S A       Date:  2021-08-03       Impact factor: 12.779

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.